Effects of Change in Control. If Employee is terminated without Good Cause or resigns for Good Reason during the first twelve (12) months following a Change in Control (as defined below), Employee shall be entitled to receive a lump sum in an amount equal to # one and one-half years of salary (at the rate in effect at the time of termination); and # a bonus equal to one and one-half times the Employee’s targeted bonus for that year, which lump sum payment shall be made within ten (10) business days following the date on which the Release has been executed, delivered and becomes irrevocable, such to Section 8.16(b)(v) below. Should Employee elect continuation of his group medical insurance coverage and dental insurance coverage for Employer and his spouse and dependent children, pursuant to COBRA, then Employer will pay its portion of the premium costs associated with such election for a period of up to eighteen (18) months after Employee’s election of COBRA, provided that such medical and dental coverage will terminate sooner if Employee becomes eligible for coverage under another employer’s plan. To be eligible for the compensation provided for in this Section 5.5, Employee must execute and not revoke a Release within the time frame specified in Section 8.16.(b)(v). Employer shall have no further obligations to Employee under this Agreement.

If there is a Change of Control, then the Party experiencing such Change of Control (“Acquired Party”) shall provide written notice to the other Party (“Non-Acquired Party”) at least ​ days ​ of such Change of Control, subject to any confidentiality obligations of the Acquired Party then in effect ​.

Effects of Change of Control. If, during the Term, MTEM undergoes a Change of Control, from and after the closing of such Change of Control, MTEM and its Preexisting Affiliates, on the one hand, and the acquirer and its Affiliates (other than MTEM and its Preexisting Affiliates), on the other hand, shall establish and enforce internal processes, policies, procedures and systems to segregate BMS’s Confidential Information, including Research Plans and reports pursuant to ARTICLE 2 and reports pursuant to ARTICLE 6 and ARTICLE 7, such that the acquirer and its Affiliates (other than MTEM and its Preexisting Affiliates) do not obtain access to Confidential Information of BMS. In addition, in the case of

Change of Control. There occurs any Change of Control.

Change of Control. There occurs any Change of Control.

Change of Control. If a Change of Control occurs before the end of the Performance Period, the target performance level of the Award will be deemed to have been achieved and you will be deemed to have earned the Award at a payout percentage of 100% of target Awards.

General: Notwithstanding any other provision in the Plan to the contrary, and except as otherwise provided in Section 14(b), the following provisions shall apply in the event of a Change of Control (except to the extent, if any, otherwise required under Code [Section 409A] or provided in an Award Agreement):

Effects of Fate Change of Control. In the event of the occurrence of a Change of Control of Fate during the Term, the following provisions of this [Section 17.14] shall apply:

Effects of Change of Control of CRISPR. If, during the Agreement Term, CRISPR undergoes a Change of Control to a Competitor, then upon the effective date of such Change of Control ​.

Effects of Change of Control. If there is a Change of Control of [[Merus:Organization]] during the Research Term, then [[Merus:Organization]] shall continue to conduct the Research Program, in accordance with the terms of this Agreement, and the Research Continuance Scenario set forth in [Section 15.8.2(b)] shall apply. Notwithstanding the foregoing, solely where # such Change of Control occurs following ​, # at such time, [[Merus:Organization]] has generated at ​ for such Research Program, and # the Acquirer is ​, Lilly may elect, by written notice to [[Merus:Organization]], which notice shall be delivered, if at all, within ​ following the applicable notice of such Change of Control delivered to Lilly pursuant to [Section 15.8.1], to either continue with the Research Continuance Scenario set forth in [Section 15.8.2(b)], or to step in to assume responsibility for the conduct of the remaining activities pursuant to each Research Plan (the “Research Activities”), in which case the Research Transfer Scenario set forth in [Section 15.8.2(a)] shall apply.